The Clinical Times
The Front Page of Medicine

Latest medical news · page 147

The latest headlines across every section, pulled from official and open-access sources.

JAMA Network Open · Jun 25, 2026

Medical Record Abstraction for Quality Improvement in Sepsis Care Using AI

This cluster randomized trial assesses whether the receipt of targeted feedback based on artificial intelligence (AI)-enabled medical record abstraction can improve physician compliance with the Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock Management Bundle.

NHS England · Jun 24, 2026

NHS to offer new immunotherapy for hundreds of women with aggressive cervical cancer

Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term. Pembrolizumab – which experts describe as being able to ‘take the handbrake off the body’s immune system’ to target cancer – will now offer a new […]

MedCity News · Jun 24, 2026

Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t

Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News .

FDA Drugs · Jun 24, 2026

Drug Trials Snapshots webpage

Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent.

ADA (Diabetes) · Jun 24, 2026

New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults

New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults mcarmody Wed, 06/24/2026 - 17:26 Press release New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ARLINGTON, Va. June 29, 2026 Today, the Obesity Association, a division of the American Diabetes Association ® (the association), announced the next section in the Standards of Care in Overweight and Obesity, “ Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ,” published in Diabetes…

FDA Drugs · Jun 24, 2026

PRE-FORMANCE BLACK may be harmful due to hidden ingredient

The Food and Drug Administration is advising consumers not to purchase or use PRE-FORMANCE BLACK, a product promoted to boost energy and increase performance on various websites, including Advancedsupps.com, and possibly in some retail stores.

MHRA (UK) · Jun 24, 2026

Transparency data: MHRA Performance Data

Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.

FDA Drugs · Jun 24, 2026

FDA approves palbociclib with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of HR-positive, HER2-positive metastatic breast cancer

On June 24, 2026, the Food and Drug Administration approved palbociclib (Ibrance, Pfizer Inc.) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adults with HR-positive, HER2-positive locally advanced or metastatic breast cancer follo

ACC (Cardiology) · Jun 24, 2026

FXN Gene Therapy Shows Promise in Treating Patients With FA Cardiomyopathy

In patients with Friedreich ataxia (FA) cardiomyopathy, intravenous administration of AAVrh.10hFXN, an rh.10 serotype cardiotropic adenoassociated virus vector expressing the normal human FXN coding sequence, was well tolerated and showed promise as a potential treatment...

← NewerOlder →

Back to the live front page